At a glance
ClinicalIndex Comparison RecordN/ACompleted· 406 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
National Cardiogenic Shock Initiative
In Brief
An observational study for Cardiogenic Shock and 4 related conditions. Completed, enrolled 406 participants across 75 sites.
Detailed Summary
This study evaluates the use of early mechanical circulatory support in patients presenting with acute myocardial infarction and cardiogenic shock. Patients are treated according to the National Cardiogenic Shock Initiative protocol, which emphasizes early identification of cardiogenic shock and rapid delivery of mechanical circulatory support based on invasive hemodynamics. All patients treated in this manner are enrolled in the National Cardiogenic Shock registry.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCardiogenic Shock, Acute Myocardial Infarction, STEMI - ST Elevation Myocardial Infarction, NSTEMI - Non-ST Segment Elevation MI, Heart Attack
CountriesUnited States
CollaboratorsAbiomed Inc., Chiesi Farmaceutici S.p.A.
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
Enrollment StartMay 2016
First PostedSep 2018
Primary CompletionDec 2020
Study CompletionDec 2020
TodayJul 2026
First PostedSep 19, 2018
Enrollment StartMay 19, 2016
Primary CompletionDec 1, 2020
Study CompletionDec 31, 2020
TodayJul 2, 2026
Enrollment to primary: 4.5 yearsPosted 7.8 years ago